Document is current
Any future updates will be listed below
-
Authors
Chang, Yun
Bai, Rui
Zhang, Yongshuai
Lu, Wen-jing
Ma, Shuhong
Zhu, Min
Lan, Feng https://orcid.org/0000-0002-9038-4014
Jiang, Youxu
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2021YFC2701700)
Key Technologies Research and Development Program (2021YFC2701703)
Shenzhen Fundamental Research Program (ZDSYS20200923172000001)
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 26 August 2024
First Online: 8 October 2024
Declarations
:
: Human induced pluripotent stem cells were derived from human urine cells with written consent from the donors, and the study was approved by the Ethics Committee of Beijing Anzhen Hospital (“Clinical genetic testing program for hereditary cardiovascular disease” on July 14, 2016, with Registration Number 2016015). Human embryonic stem cells H9 was obtained from the WiCell Research Institute, with ethical approval available at hpscreg (<u>).</u>
: Not applicable.
: The authors declare that they have no conflict of interests.
